Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Immatics at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Immatics brings 2 presentations to SITC 2026 in Phoenix, and exhibits at Booth 1119, 715. Its program focuses on T cell receptor based treatments for solid tumors, both engineered T cells and bispecific engagers. Concrete topics include what the PRAME target is teaching about TCR T-cell therapy and early clinical results for engagers aimed at PRAME and MAGEA4/8.

Organization

SITC 2026 Attendance

Tübingen, Germany

Biotech

Develops PRAME-targeted TCR T-cell therapies and TCR bispecifics for solid tumors.

Booth

Exhibiting at Booth 1119, 715

Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm

Talk

Thu Nov 5
8:35am–8:45am

Part of Session I: Cell Therapies and Technologies

From Antigen Selection to Clinical Activity: What PRAME is Teaching us About TCR T-cell Therapy in Solid Tumors

Valley of the Sun Ballroom

Cell therapy

Talk

Thu Nov 5
11:00am–11:10am

Part of Session II: Immune Cell Engagers and Bispecifics

Initial Clinical Results with T-cell Receptor (TCR)-based Bispecific T-cell Engagers (TCERs) Targeting PRAME and MAGEA4/8 in Advanced Solid Tumors

Valley of the Sun Ballroom

New agents · Clinical

Instantly find 20 buyers from Immatics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction